Neogen Corporation logo NEOG - Neogen Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 6
SELL 1
STRONG
SELL
0
| PRICE TARGET: $11.00 DETAILS
HIGH: $12.00
LOW: $10.00
MEDIAN: $11.00
CONSENSUS: $11.00
UPSIDE: 23.60%

Stock News

Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification

Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that its Molecular Detection Assay - Listeria Right Now™ rapid environmental monitoring test has received AOAC® Performance Tested Methods℠ (PTM) certification (No. 042604), validating the test's performance for the enrichment-free detection of viable and non-viable Listeria species on stainless steel surfaces. The technology allows technicians to perform the assay.

Apr 23, 2026 04:45 AM businesswire.com
Neogen Reports Third Quarter Fiscal Year 2026 Financial Results

Neogen Reports Third Quarter Fiscal Year 2026 Financial Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal third quarter of 2026 and provided updated full fiscal year 2026 financial guidance. “We continued to make significant progress on our strategic transformation in the third quarter as we look to stabilize and strengthen our core business. We are emboldened by the continued strength in core growth in our Food Safety segment. Combined w.

Apr 09, 2026 03:00 AM businesswire.com
Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive experience in the life sciences industry. She has served more than 10 years as a public company chief legal and compliance officer and board secretary, as well as fiv.

Apr 08, 2026 04:00 AM businesswire.com
Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026

Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company's performance for the third-quarter of fiscal year 2026. The conference call can be accessed by.

Mar 30, 2026 04:00 AM businesswire.com
Contrasting Sunny Optical Technology (Group) (OTCMKTS:SNPTF) and Neogen (NASDAQ:NEOG)

Contrasting Sunny Optical Technology (Group) (OTCMKTS:SNPTF) and Neogen (NASDAQ:NEOG)

Neogen (NASDAQ: NEOG - Get Free Report) and Sunny Optical Technology (Group) (OTCMKTS:SNPTF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Profitability This table compares Neogen and Sunny

Mar 20, 2026 09:12 PM defenseworld.net
Neogen Announces Sale of Genomics Business to Zoetis

Neogen Announces Sale of Genomics Business to Zoetis

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. (“Zoetis”), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the company's portfolio review strategy to simplify the business and focus on core s.

Mar 02, 2026 02:00 AM businesswire.com

Price Targets